SREBF2 and polycystic ovary syndrome: Given that SREBP2 and RANKL are both involved in disorders of cholesterol metabolism in non-obese subjects with NAFLD, we boldly speculate that SREBP2 might mediate the role of RANKL in NAFLD in young PCOS women with normal weight.